KappArest™ is a proprietary formula designed to downregulate inflammatory pathways, primarily through the inhibition of NF-kappaB, a molecule inside each cell. Many disease conditions are associated with inappropriate activation of nuclear transcription factor kappaB (NF-KappaB). The modulation of NF-KappaB has become a major therapeutic goal in the management of a wide range of illnesses. KappArest™ supplies a broad array of antioxidants and phytonutrient components, demonstrated to suppress the activation of NF-kappaB, and associated kinases, including AP-1. Seven of the eight ingredients have documented activity in suppressing NF-KappaB. Phytolens, a Biotics Research patented extract from lentil, has also demonstrated broad antioxidant properties, and displays potent free radical scavenging ability, resulting in marked benefits on the inflammatory process.
Proprietary Blend of Curcuma Longa (emulsified root extract† and rhizome power), Boswellia (Boswellia serrata) (gum) (extract), Propolis, Green Tea (Camellia sinensis) (leaf) (extract), Ginger (Zingiber officinale) (rhizome) (extract), Rosemary (Rosemarinus officinalis) (aerial part) (extract), Celery (Apium graveolens) (seed) (extract), Alpha-Lipoic Acid, Trans-Resveratrol, Phytolens® (Lens esculenta) (extract) (husk), Bioperine® (Piper nigrum) (extract) (fruit)
†Phytolens® is registered trademark of Biotics Research Corporation. U.S. Patent # 5,762,936.
‡Bioperine® is a registered trademark of Sabinsa Corporation.
Capsule shell (gelatin and water), cellulose, silica and magnesium stearate (vegetable source).